ALK and lung cancer: Li et al. (2017) identified in a prospective study, using RT-qPCR on plasma samples from 71 patients (41 ALK-positive), a panel of three circulating miRNAs that can discriminate between patients diagnosed with ALK-positive and ALK-negative lung cancers.